IRadimed Corporation

NASDAQ: IRMD · Real-Time Price · USD
70.23
0.08 (0.11%)
At close: Aug 15, 2025, 2:57 PM

IRadimed Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
20.41M 19.51M 19.39M 18.33M 17.93M 17.6M 17.45M 16.5M 16.13M 15.48M 14.86M 13.41M 12.72M 12.31M 11.87M 10.91M 9.81M 9.22M
Cost of Revenue
4.45M 4.67M 4.63M 4.13M 3.92M 4.21M 4.04M 3.67M 3.94M 3.75M 3.64M 2.86M 2.58M 2.93M 2.62M 2.5M 2.48M 2.16M
Gross Profit
15.95M 14.84M 14.76M 14.19M 14.01M 13.39M 13.41M 12.84M 12.19M 11.72M 11.22M 10.54M 10.14M 9.38M 9.25M 8.41M 7.33M 7.06M
Operating Income
6.79M 5.43M 5.8M 5.79M 5.63M 4.75M 5.16M 5.91M 4.96M 4.01M 4.25M 4.13M 4.17M 3.07M 3.11M 3.09M 1.84M 1.78M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
7.33M 5.95M 6.34M 6.42M 6.27M 5.24M 5.68M 6.41M 5.3M 4.35M 4.7M 4.24M 4.18M 3.06M 3.11M 3.09M 1.86M 1.77M
Net Income
5.77M 4.69M 5.15M 5.05M 4.9M 4.14M 4.54M 5.07M 4.18M 3.41M 3.67M 3.43M 3.24M 2.49M 3.89M 2.58M 1.47M 1.39M
Selling & General & Admin
8.29M 8.79M 8.39M 7.76M 7.58M 7.82M 7.6M 6.48M 6.26M 6.92M 6.36M 5.92M 5.31M 5.79M 5.65M 4.84M 5.03M 4.81M
Research & Development
877.36K 624.25K 569.99K 639.47K 801.13K 3.83M 650.43K 452.56K 961.95K 793.72K 604.74K 491.64K 662.6K 519.1K 494.85K 480.7K 453.68K 475.82K
Other Expenses
n/a n/a n/a n/a n/a 495.15K n/a n/a n/a n/a n/a n/a 13.1K -14.91K 3.93K 7.14K 13.2K -5.66K
Operating Expenses
9.17M 9.41M 8.96M 8.4M 8.38M 8.64M 8.25M 6.93M 7.22M 7.71M 6.97M 6.41M 5.97M 6.3M 6.14M 5.32M 5.49M 5.29M
Interest Expense
n/a n/a n/a n/a n/a n/a 342.41K n/a n/a n/a n/a n/a n/a 14.91K n/a n/a n/a n/a
Selling & Marketing Expenses
4.01M 4.18M 4.52M 3.8M 3.48M 3.83M 3.33M 2.86M 2.78M 3M 3.66M 3.04M 2.91M 3.07M 3.12M 2.59M 2.47M 2.38M
Cost & Expenses
13.62M 14.08M 13.59M 12.54M 12.3M 12.85M 12.29M 10.6M 11.17M 11.47M 10.61M 9.27M 8.55M 9.24M 8.76M 7.82M 7.97M 7.45M
Income Tax Expense
1.55M 1.26M 1.2M 1.37M 1.37M 1.11M 1.14M 1.34M 1.12M 943.59K 1.03M 810.38K 938.63K 573.29K -779.17K 517.77K 387.73K 384.49K
Shares Outstanding (Basic)
12.72M 12.71M 12.68M 12.67M 12.66M 12.66M 12.62M 12.6M 12.6M 12.62M 12.57M 12.56M 12.56M 12.55M 12.43M 12.33M 12.31M 12.31M
Shares Outstanding (Diluted)
12.83M 12.83M 12.78M 12.78M 12.76M 12.75M 12.74M 12.74M 12.72M 12.69M 12.63M 12.63M 12.63M 12.66M 12.63M 12.6M 12.55M 12.52M
EPS (Basic)
0.45 0.37 0.41 0.40 0.39 0.33 0.36 0.40 0.33 0.27 0.29 0.27 0.26 0.20 0.31 0.21 0.12 0.11
EPS (Diluted)
0.45 0.37 0.40 0.40 0.38 0.32 0.36 0.40 0.33 0.27 0.29 0.27 0.26 0.20 0.31 0.20 0.12 0.11
EBITDA
6.79M 5.63M 6.54M 5.79M 5.63M 5.47M 5.89M 5.91M 5.15M 4.19M 4.42M 4.57M 4.66M 3.51M 3.5M 3.43M 2.19M 2.11M
EBIT
n/a 5.95M 4.66M 5.79M 6.27M 5.24M 5.68M 6.41M 5.3M 4.01M 4.25M 4.24M 4.18M 3.06M 3.11M 3.09M 1.86M 1.77M
Depreciation & Amortization
n/a 194.12K 194.87K 197.57K 199.13K 226.09K 205.38K 189.83K 187.36K 182.55K 174.82K 167.63K 168.1K 160.13K 161.25K 156.8K 162.7K 153.26K